CG
SYRS

Cutler Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Cutler Group’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-190
Closed -$17K – 4834
2019
Q2 		$17K Sell
190
-10
-5% -$696 ﹤0.01% 2348
2019
Q1 		$18K Sell
200
-220
-52% -$15.3K ﹤0.01% 2127
2018
Q4 		$23K Buy
420
+400
+2,000% +$30.4K ﹤0.01% 2029
2018
Q3 		$2K Sell
20
-20
-50% -$2.32K ﹤0.01% 3614
2018
Q2 		$4K Buy
40
+30
+300% +$3.71K ﹤0.01% 3288
2018
Q1 		$1K Sell
10
-820
-99% -$89.7K ﹤0.01% 4217
2017
Q4 		$80K Buy
+830
New +$111K ﹤0.01% 1525

Other funds holding SYRS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Cutler Group's SYRS Position: Q3 2019 in Review

Cutler Group sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q3 2019, closing a stake of 190 shares — an estimated $17K sold.

Cutler Group first reported a position in SYRS in Q4 2017 and held it in 7 quarters. The position peaked at $80K in Q4 2017. 62 funds tracked by Wall St. Rank hold SYRS as of Q3 2019.

  • Cutler Group reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Cutler Group sold 190 Syros Pharmaceuticals, Inc. Common Stock shares in Q3 2019, an estimated $17K.
  • Cutler Group first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 7 quarters.
  • Cutler Group's Syros Pharmaceuticals, Inc. Common Stock position peaked at $80K in Q4 2017.
  • 62 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q3 2019.

Based on Cutler Group's 13F filing for Q3 2019, filed 28 Oct 2019.